Dr Alan Schechter of the Molecular Medicine Branch at the National Institutes of Health in Bethesda, Maryland and his colleagues discuss research during the last two decades that has revealed a second major pathway for Nitric Oxide formation in mammals.
Here, we learn about the many uses of spirulina algae, and how BBI JU funded project SpiralG is assessing the sustainability and profitability of each spirulina biomass component.
Professor Darren Griffin reflects on how patients in fertility clinics should interpret the scientific evidence base when even the experts can’t seem to agree.
The Bharat Biotech COVID vaccine, COVAXIN, appears to be 81% efficient against the virus in Phase Three of clinical trials.
A study examining older people in the UK found that only one dose of the AstraZeneca vaccine is atleast 60% effective for people aged 70 and over.
An international research team have discovered that the genetics of eating disorders and some psychiatric disorders have some similarities, raising new questions about treatment for both.
Researchers at Yale believe that blood tests could predict severe or critical COVID cases, because blood holds a series of interesting biological signals about a person.
The US Food and Drug Administration (FDA) approved the Johnson & Johnson vaccine, with an efficacy of 86%, as the next to be rolled out across the US.
New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.
Germans have only taken 270,986 AstraZeneca doses so far, leaving roughly 1.17 million doses in storage across the country - but these shots are due to expire in less than six months.
Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth, describes Horizon Europe and scaling up high-impact and breakthrough research & innovation.
New data from the REACT study finds that 14% of the UK population have antibodies against COVID-19 now, but that vaccine hesitancy is currently highest in London.
The first Horizon Europe grants will be launched today (25 February), with Starting Grants for researchers worth €619 million available.
The Californian COVID mutation appears to be as infectious as the UK or South African mutations - but does it have the potential to be more deadly?
New documents from the FDA show that the Johnson & Johnson vaccine appears to be 86% effective against COVID-19 - signalling that it will soon be approved in the US.
Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
Michael Morrison, Senior Researcher in Social Science at the Centre for Health, Law and Emerging Technologies (HeLEX), University of Oxford, sheds light on the promises as well as biomodifying technologies for the UK.
Dr Alistair Davidson, Director, Consortium for Battery Innovation, describes accelerating innovation when it comes to the use of lead batteries in the future.
The research team believe that some people have a genetic predisposition that increases likelihood of severe COVID, which may be crucial to understanding how mutations could change outcomes.
The highest risk revealed by this research is for adolescent boys aged 16, who face a strong chance of becoming temporarily addicted to the internet.